[1] World Health Organization. Global tuberculosis report 2024. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2024. [Accessed at Dec 10, 2024].
[2] Li W, Wang X, Bi B, et al. Influence of Temperature and Humidity on the Incidence of Pulmonary Tuberculosis in Hainan, China, 2004–2018. Biomed Environ Sci, 2024; 37(9), 1080-1085.
[3] Fan Y, Liu D, Chen Y, et al. Inferring Mycobacterium Tuberculosis Drug Resistance and Transmission using Whole-genome Sequencing in a High TB-burden Setting in China. Biomed Environ Sci, 2024; 37(2), 157-169.
[4] Leung CC, Yew WW, Chan CK, et al. Smoking adversely affects treatment response, outcome and relapse in tuberculosis. Eur Respir J, 2015; 45, 738−745. doi:  10.1183/09031936.00114214
[5] Sun Q, Li S, Gao M, et al. Therapeutic Strategies for Tuberculosis: Progress and Lessons Learned. Biomed Environ Sci, 2024; 37(11), 1310-1323.
[6] Guo C, Nie L, Song Y, et al. Efficacy and Safety of Combined Bedaquiline and Delamanid Use among Patients with Multidrug-Resistant Tuberculosis in Beijing, China. Biomed Environ Sci, 2024; 37(10), 1195-1203.
[7] Quan DH, Kwong AJ, Hansbro PM, et al. No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis. Eur Respir Rev, 2022; 31.
[8] Gai X, Cao W, Rao Y, et al. Risk factors and biomarkers for post-tuberculosis lung damage in a Chinese cohort of male smokers and non-smokers: protocol for a prospective observational study. BMJ Open, 2023; 13, e065990. doi:  10.1136/bmjopen-2022-065990
[9] Gai X, Allwood B, Sun Y. Post-tuberculosis lung disease and chronic obstructive pulmonary disease. Chin Med J (Engl), 2023; 136, 1923−1928. doi:  10.1097/CM9.0000000000002771
[10] Rao Y, Cao W, Qu J, et al. More severe lung lesions in smoker patients with active pulmonary tuberculosis were associated with peripheral NK cell subsets. Tuberculosis (Edinb), 2023; 138, 102293. doi:  10.1016/j.tube.2022.102293
[11] Rao Y, Gai X, Le Y, et al. Enhanced Proinflammatory Cytokine Production and Immunometabolic Impairment of NK Cells Exposed to Mycobacterium tuberculosis and Cigarette Smoke. Front Cell Infect Microbiol, 2021; 11, 799276.
[12] Sato Y, Silina K, van den Broek M, et al. The roles of tertiary lymphoid structures in chronic diseases. Nat Rev Nephrol, 2023; 19, 525−537.
[13] Zhao R, Zhang J, Ma J, et al. cGAS-activated endothelial cell-T cell cross-talk initiates tertiary lymphoid structure formation. Sci Immunol, 2024; 9, eadk2612. doi:  10.1126/sciimmunol.adk2612
[14] Xiong J, Zhou L, Tian J, et al. Cigarette Smoke-Induced Lymphoid Neogenesis in COPD Involves IL-17/RANKL Pathway. Front Immunol, 2020; 11, 588522.
[15] John-Schuster G, Hager K, Conlon TM, et al. Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD. Am J Physiol Lung Cell Mol Physiol, 2014; 307, L692−706. doi:  10.1152/ajplung.00092.2014
[16] Global initiative for chronic obstructive lung disease, GOLD 2025. https://goldcopd.org/wp-content/uploads/2024/11/GOLD-2025-Report-v1.0-15Nov2024_WMV.pdf.
[17] National Health and Family Planning Commission of the People's Republic of China. Diagnostic criteria for tuberculosis (WS 288—2017). Electronic Journal of Emerging Infectious Diseases, 2018; 3, 59−61. (In Chinese)
[18] Song Q, Guo X, Zhang L, et al. New Approaches in the Classification and Prognosis of Sign Clusters on Pulmonary CT Images in Patients With Multidrug-Resistant Tuberculosis. Front Microbiol, 2021; 12, 714617. doi:  10.3389/fmicb.2021.714617
[19] Linge I, Tsareva A, Kondratieva E, et al. Pleiotropic Effect of IL-6 Produced by B-Lymphocytes During Early Phases of Adaptive Immune Responses Against TB Infection. Front Immunol, 2022; 13, 750068. doi:  10.3389/fimmu.2022.750068
[20] Ulrichs T, Kosmiadi GA, Trusov V, et al. Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J Pathol, 2004; 204, 217−228. doi:  10.1002/path.1628
[21] Chen Y, Bharrhan S, Xu J, et al. B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice. PLoS Pathog, 2023; 19, e1011187. doi:  10.1371/journal.ppat.1011187
[22] Slight SR, Rangel-Moreno J, Gopal R, et al. CXCR5⁺ T helper cells mediate protective immunity against tuberculosis. J Clin Invest, 2013; 123, 712−726.
[23] Linge I, Kondratieva E, Apt A. Prolonged B-Lymphocyte-Mediated Immune and Inflammatory Responses to Tuberculosis Infection in the Lungs of TB-Resistant Mice. Int J Mol Sci, 2023; 24.
[24] Linge I, Kondratieva T, Apt A. B-cell follicles in tuberculous lung: Active defenders or modest bystanders? Immunology, 2023; 169, 515-518.
[25] Gopal R, Rangel-Moreno J, Slight S, et al. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol, 2013; 6, 972−984. doi:  10.1038/mi.2012.135
[26] Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med, 2004; 350, 2645−2653. doi:  10.1056/NEJMoa032158
[27] Saint-André V, Charbit B, Biton A, et al. Smoking changes adaptive immunity with persistent effects. Nature, 2024; 626, 827−835. doi:  10.1038/s41586-023-06968-8
[28] Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature, 2006; 441, 231−234. doi:  10.1038/nature04754
[29] Marin ND, Dunlap MD, Kaushal D, et al. Friend or Foe: The Protective and Pathological Roles of Inducible Bronchus-Associated Lymphoid Tissue in Pulmonary Diseases. J Immunol, 2019; 202, 2519−2526. doi:  10.4049/jimmunol.1801135
[30] Zhao L, Jin S, Wang S, et al. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances. Signal Transduct Target Ther, 2024; 9, 225. doi:  10.1038/s41392-024-01947-5
[31] Yang F, Yang J, Wu M, et al. Tertiary lymphoid structures: new immunotherapy biomarker. Front Immunol, 2024; 15, 1394505. doi:  10.3389/fimmu.2024.1394505